The effectiveness of intravenous (IV) to oral (PO) antibiotic switch (IVOS) interventions in managing community- and hospital-acquired pneumonia—a systematic review
JAC-Antimicrobial Resistance · 30.04.2026 · 8 (3)
DOI: 10.1093/jacamr/dlag065 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 12.05.2026. Verfasst von Nketia Obed-Arthur und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Reading, Whiteknights Campus, Reading, England RG6 2AH, UK. Die Arbeit nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wilkie Calvert, University of Reading.
Themen: Pneumonieprophylaxe
Abstract (Originalsprache)
Background
Prolonged intravenous (IV) antibiotic therapy in hospitalized patients with pneumonia increases healthcare costs and hospital length of stay compared to oral (PO) therapy. Antimicrobial stewardship (AMS) interventions promoting timely IV-to-PO antibiotic conversion may reduce healthcare burden without compromising patient outcomes. Optimal design and implementation of such interventions in different healthcare settings, including respiratory medicine remain unclear.
Objectives
The aim of this study was to evaluate the effectiveness of interventions designed to improve IV-to-PO antibiotic switching practices in managing community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP).
Methods
The review was registered with PROSPERO (CRD420251039180). PubMed, Scopus, Web of Science, The Cochrane Library databases were searched for studies published from 1995 to 2024 focusing on CAP and/or HAP management or antimicrobials indicated for respiratory infections. Two reviewers independently screened studies using a priori inclusion/exclusion criteria. Study quality was assessed using the Mixed Methods Appraisal Tool. Data were analysed using narrative synthesis. Clinical outcomes (cure rates, mortality, length of stay), economic outcomes (cost savings), and process measures (switching rates, IV antibiotic duration) were examined.
Results
58 studies were included. Interventions included clinical guideline/protocol implementation (n = 40), pharmacist-led interventions (n = 21), educational programmes (n = 7), computerized decision support systems (n = 5), audit/feedback systems (n = 3), and multidisciplinary team approaches (n = 1). Most studies demonstrated 1–4-day reductions in IV antibiotic duration, 1–2 day reductions in hospital length of stay, and cost savings, while maintaining equivalent clinical outcomes. Multimodal approaches outperformed single interventions.
Conclusion
Existing AMS interventions effectively promote IV-to-PO switching in CAP/HAP management. Healthcare systems should consider more than one intervention to optimize IV-to-PO antibiotic switch.
Autor:innen und Institutionen
- School of Pharmacy, University of Reading, Whiteknights Campus, Reading, England RG6 2AH, UK.
- Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.
ORCID-Profile: Rosemary H M Lim
Förderung
- Wilkie Calvert
- University of Reading
Zitieren
APA
Obed-Arthur, N., Lim, R. H. M., & Dunsmure, L. (2026). The effectiveness of intravenous (IV) to oral (PO) antibiotic switch (IVOS) interventions in managing community- and hospital-acquired pneumonia—a systematic review. JAC-Antimicrobial Resistance, 8(3). https://doi.org/10.1093/jacamr/dlag065
Vancouver
Obed-Arthur N, Lim RHM, Dunsmure L. The effectiveness of intravenous (IV) to oral (PO) antibiotic switch (IVOS) interventions in managing community- and hospital-acquired pneumonia—a systematic review. JAC-Antimicrobial Resistance. 2026;8(3). doi:10.1093/jacamr/dlag065
BibTeX
@article{ObedArthur2026,
author = {Obed-Arthur, Nketia and Lim, Rosemary H M and Dunsmure, Louise},
title = {The effectiveness of intravenous (IV) to oral (PO) antibiotic switch (IVOS) interventions in managing community- and hospital-acquired pneumonia—a systematic review},
journal = {JAC-Antimicrobial Resistance},
year = {2026},
volume = {8},
number = {3},
doi = {10.1093/jacamr/dlag065}
}
EUVIMED